Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10

Thrombosis Research

Volumn 113, Issue 3-4, 2004, Pages 205-209

  Gunther, Karen E ^a   Conway, Gladys ^a   Leibach, Linda ^a   Crowther, Mark A ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b ST JOSEPH S HOSPITAL   (Canada)

Author keywords

Anticoagulation; INR; international normalized ratio; Vitamin K; Warfarin

Indexed keywords

VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HOSPITAL MANAGEMENT; HUMAN; INTERNATIONAL STANDARD UNIT; LOW DRUG DOSE; MALE; OUTPATIENT CARE; PATIENT CARE; PRIORITY JOURNAL; REFRACTORY PERIOD; SIDE EFFECT; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ANTIDOTES; BLOOD COAGULATION; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; OUTPATIENTS; PATIENT SELECTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAMIN K; WARFARIN;

EID: 2342620696     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.03.004     Document Type: Article

References (13)

1. Landefeld C.S., Beyth R.J. Anticoagulant-related bleeding: clinical epidemiology, prediction and prevention. Am. J. Med. 95:1993;315-328
2. Palareti G., Leali N., Coccheri S., Poggi N., Manotti C., D'Angelo A., et al. Bleeding complications of oral anticoagulant treatment: An Inception - Cohort, Prospective Collaborative study (ISCOAT). Lancet. 348:1996;423-428
3. Beyth R.S., Quinn L.M., Landefeld C.S. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am. J. Med. 105:1998;91-99
4. Linkins L.A., Choi P.T., Douketis J.D. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann. Intern. Med. 139(11):2003;893-900
5. Cannegieter S.C., Rosendaal F.R., Wintzen A.R., van der Meer F.J.M., Vandenbroucke J.P., Briet E. Optimal intensity of anticoagulation in patients with mechanical heart valves. N. Engl. J. Med. 1995
6. Poller L., Shicich C.R., MacCullum K. Multicentre randomised study of computerised anticoagulant dosage: European concerted action on anticoagulation. Lancet. 352:1998;1305-1309
7. Crowther M.A., Donovan D., Harrison L., McGinnis J., Ginsburg J. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin. Thromb. Haemost. 79:1998;1116-1118
8. Crowther M.A., Julian J., McCarty D., Douketis J., Kovaas M., Biagoni L., et al. Treatment of warfarin associated coagulopathy with oral vitamin K: a randomised controlled trial. Lancet. 356:2000;1551-1553
9. Geerts W.H., et al. Sixth ACCP consensus conference on antithrombotic therapy. Chest. 119(suppl. 1):2001;132S-175S
10. Lubetsky A., Yonath H., Olchovsky D., Loebstein R., Halkin H., Ezra D. Comparison of oral vs. intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomised controlled study. Arch. Intern. Med. 163(20):2003;2469-2473
11. Weibert R.T., Kayser S.R., Rapaport S.I. Correction of excessive anticoagulation with low-dose oral vitamin K. Ann. Intern. Med. 126:1997;959-962
12. Pergo V., Banzato A., Garelli E., Zasso A., Biasiolo A. Reversal of excessive effect of regular anticoagulation: low oral dose phytonadione (vitamin K1) compared with warfarin discontinuation. Blood Coagul. Fibrinolysis. 4:1993;739-741
13. Hylek E.M., Chang Y.C., Skates S.J., Hughes R.A., Singer D.E. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch. Intern. Med. 160(11):2000;1612-1617